BIOVERATIV INC. Depreciation and Amortization
BIOVERATIV INC. reported Depreciation and Amortization of $14.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2018-02-14
- BIOVERATIV INC. depreciation, depletion and amortization for the quarter ending 2017-12-31 was $3.00M, a 78.42% decline year-over-year.
- BIOVERATIV INC. depreciation, depletion and amortization for the quarter ending 2017-09-30 was $3.10M, a 80.86% decline year-over-year.
- BIOVERATIV INC. depreciation, depletion and amortization for the quarter ending 2017-06-30 was $2.70M, a 85.94% decline year-over-year.
- BIOVERATIV INC. depreciation, depletion and amortization for the quarter ending 2017-03-31 was $5.70M, a 39.02% increase year-over-year.
- BIOVERATIV INC. depreciation, depletion and amortization for fiscal 2017 was $14.50M, a 72.85% decline from fiscal 2016.
- BIOVERATIV INC. depreciation, depletion and amortization for fiscal 2016 was $53.40M, a 242.31% increase from fiscal 2015.
- BIOVERATIV INC. depreciation, depletion and amortization for fiscal 2015 was $15.60M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2017-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $6.10M derived: sum of 2 quarters · filed 2018-02-14 | $8.80M derived: sum of 3 quarters · filed 2018-02-14 | $14.50M 10-K · filed 2018-02-14 |
| 2017-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $5.80M derived: sum of 2 quarters · filed 2017-10-27 | $11.50M 10-Q · filed 2017-10-27 | $25.40M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.40M 10-Q · filed 2017-08-03 | $22.30M derived: sum of 3 quarters · filed 2018-02-14 | $38.50M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $5.70M 10-Q · filed 2017-05-12 | $19.60M derived: sum of 2 quarters · filed 2018-02-14 | $35.80M derived: sum of 3 quarters · filed 2018-02-14 | $55.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $30.10M derived: sum of 2 quarters · filed 2018-02-14 | $49.30M derived: sum of 3 quarters · filed 2018-02-14 | $53.40M 10-K · filed 2018-02-14 |
| 2016-09-30 | $16.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $35.40M derived: sum of 2 quarters · filed 2017-10-27 | $39.50M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $19.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $23.30M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $4.10M 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $15.60M 10-K · filed 2018-02-14 |